ASTRIA THERAPEUTICS INC (ATXS) Stock Income Statement
NASDAQ:ATXS - Nasdaq - US04635X1028 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 116.17M | 83.03M | 53.50M | 194.98M | 37.44M | |||
| Research and Development | 83.81M | 57.33M | 34.26M | 180.17M | 25.59M | |||
| Selling, General, and Administrative Expenses | 32.35M | 25.70M | 19.24M | 14.81M | 11.85M | |||
| Operating Income | -116.17M | -83.03M | -53.50M | -194.98M | -37.44M | |||
| Interest Income/Expense | 16.20M | 10.20M | 1.72M | 120.00K | 240.00K | |||
| Other Income/Expense | -80.00K | -62.00K | -60.00K | -60.00K | -100.00K | |||
| Income Before Taxes | -100.04M | -72.89M | -51.83M | -194.91M | -37.30M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -100.04M | -72.89M | -51.83M | -219.35M | -37.30M | |||
| EBITDA | N/A | N/A | N/A | N/A | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.09 | -2.42 | -3.55 | -24.58 | -12.19 | |||
| Non GAAP EPS | -2.17 | -2.42 | -3.63 | -14.31 | -12.18 | |||
| Statistics | ||||||||
| Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
| Operating Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
All data in USD